Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6324637 | 1.00 | BACE1 (0.35) | BACE1NOTUM | |
| SCHEMBL6318605 | 0.71 | NOTUM (0.33) | NOTUM | |
| SCHEMBL6256436 | 0.70 | ALPL (0.36) | BACE1 | |
| SCHEMBL6256444 | 0.70 | ALPL (0.36) | BACE1 | |
| SCHEMBL6324258 | 0.67 | NOTUM (0.33) | NOTUM | |
| SCHEMBL6322811 | 0.67 | NR3C1 (0.33) | NOTUM | |
| Methylhydroquinone SCHEMBL27731320 | 0.61 | TP53 (0.46) | — | |
| SCHEMBL2629264 | 0.61 | HCAR3 (0.43) | NOTUM | |
| SCHEMBL22807570 | 0.58 | BACE1 (0.49) | BACE1 | |
| SCHEMBL17754561 | 0.57 | MAPT (0.50) | BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050143349-A1 | Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels | QUATRX PHARMACEUTICALS CO. | 2005-06-30 | — | — | US | claimed |
| US-20050143349-A1 | Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels | QUATRX PHARMACEUTICALS CO. | 2005-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143349-A1 | Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels | APOB, LDLR, LPL | BACE1 482/4885NOTUM 3343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.